Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/18/19 → 4/27/22 |
Funding
- AMGen: $6,931.00
A Phase 4, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Chronic Migraine and Medication Overuse Headache
- Kapoor, Siddharth (PI)